Amal Therapeutics SA is a spin-off from the University of Geneva. Amal develops KISIMA, its proprietary vaccine technology platform to progress therapeutic vaccines in oncology. KISIMA combines in one single recombinant protein a vector for targeted antigen delivery, a toll like receptor peptide agonist as adjuvant and a chimeric multi-antigenic construct as vaccine. The platform technology is versatile and flexible, adaptable to a large spectrum of antigens, cancer indications and can further be developed to single patient\u2019s tailored cancer medicine.<\/p>\n\n\n\n
On July 15, Boehringer Ingelheim acquired Amal for up to \u20ac325m.<\/p>\n","protected":false},"excerpt":{"rendered":"
Amal Therapeutics SA is a spin-off from the University of Geneva. Amal develops KISIMA, its proprietary vaccine technology platform to progress therapeutic vaccines in oncology. KISIMA combines in one single recombinant protein a vector for targeted antigen delivery, a toll like receptor peptide agonist as adjuvant and a chimeric multi-antigenic construct as vaccine. The platform Read the full article…<\/a><\/p>\n","protected":false},"author":2,"featured_media":182,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":[],"categories":[11,13,4,16],"tags":[],"_links":{"self":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts\/181"}],"collection":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/comments?post=181"}],"version-history":[{"count":2,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts\/181\/revisions"}],"predecessor-version":[{"id":712,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/posts\/181\/revisions\/712"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/media\/182"}],"wp:attachment":[{"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/media?parent=181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/categories?post=181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/design4paper.com\/vipartners-test-live\/wp-json\/wp\/v2\/tags?post=181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}